Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: A systematic review and meta-analysis

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 113, Issue 5, 2012, Pages 618-627

  Rahimi, Hanieh ^b   Mara, Tom ^b   Costella, John ^a   Speechley, Mark ^b   Bohay, Richard ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Western Libraries ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862521046     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2011.10.010     Document Type: Article

References (27)

1. Corey L, Spear PG. Infections with herpes simplex viruses. N Engl J Med 1986;1:314:686-91.
2. Spruance SL. The natural history of recurrent oro-facial herpes simplex virus infection. Semin Dermatol 1992;11:200-6.
3. Miller CS, Danaher RJ. Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:43-50.
4. Arduino PG, Porter SR. Herpes simplex virus type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 2008;37:107-21.
5. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symtpomatology, diagnosis and management. J Am Acad Dermatol 2007;57:737-63. (Pubitemid 47553079)
6. Löwhagen GB, Tunbäck P, Bergström T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 2002;82:118-20. (Pubitemid 34596685)
7. Ribes JA, Steele AD, Seabolt J, Baker D. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001;39:3321-5. (Pubitemid 32830333)
8. Greenberg MS. Herpesvirus infections. Dent Clin North Am 1996;40:359-68.
9. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 1977;297:69-75. (Pubitemid 8122841)
10. Raborn GW, Grace MG. Recurrent herpes simplex labialis: selected therapeutic options. J Can Dent Assoc 2003;69:498-503.
11. Chon C, Nguyen L, Elliott TC. Clinical inquiries. What are the best treatments for herpes labialis? J Fam Pract 2007;56:576-8. (Pubitemid 47105640)
12. Harmenberg J, Oberg B, Spruance S. Prevention of ulcerative lesions by episodic treatment of recurrent herpes labialis: a literature review. Acta Derm Venereol 2010;90:122-30.
13. Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis 2006;12:254-70. (Pubitemid 43736414)
14. Woo SB, Challacombe SJ. Management of recurrent oral herpes simplex infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(Suppl):S12.e1-18.
15. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res 2004;61:73-81. (Pubitemid 37506094)
16. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.0.1 [updated 2008]. The Cochrane Collaboration. Available at: http://www.cochranehandbook.org.
17. Gibson JR, Klaber MR, Harvey SG, Toshi A, Jones D, Yeo JM. Prophylaxis against herpes labialis with acyclovir cream-a placebo- controlled study. Dermatologica 1986;172:104-7. (Pubitemid 16186575)
18. Spruance SL, Freeman DJ, Stewart JC, McKeough MB, Wenerstrom LG, Krueger GG, et al. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis 1991;163:728-34.
19. Raborn GW, Martel AY, Grace MG, McGaw WT. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:641-5. (Pubitemid 127669927)
20. Meyrick Thomas RH, Dodd HJ, Yeo JM, Kirby JD. Oral acyclovir in the suppression of recurrent nongenital herpes simplex virus infection. Br J Dermatol 1985;113:731-5. (Pubitemid 16186886)
21. Raborn GW, Martel AY, Grace MG, McGaw WT. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:55-9. (Pubitemid 128643688)
22. Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, et al. Oral acyclovir to suppress frequently recurrent herpes labialis: A double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-72. (Pubitemid 23046385)
23. Spruance SL, Hamill ML, Hoge WS, Davis LG, Mills J. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 1988;260:1597-9.
24. Baker D, Eisen D. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis 2003;71:239-42. (Pubitemid 38010826)
25. Miller CS, Cunningham LL, Lindroth JE, Avdiushko SA. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc 2004;135:1311-8. (Pubitemid 39329660)
26. Spruance SL, Rowe NH, Raborn GW, Thibodeau EA, D'Ambrosio JAD, Bernstein DI. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: A double- blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999;179:303-10. (Pubitemid 29086630)
27. Moher D, Schulz KF, Altman DG, Consolidated Standards of Reporting Trials Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallelgroup randomized trials. Ann Intern Med 2001;134:657-62. (Pubitemid 32322244)